How pharmaceutical industry funding affects trial outcomes: Causal structures and responses
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Daylian M. Cain & George Loewenstein & Don A. Moore, 2005. "The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest," The Journal of Legal Studies, University of Chicago Press, vol. 34(1), pages 1-25, January.
- Van Trigt, Anke M. & De Jong-Van Den Berg, Lolkje T. W. & Voogt, Linda M. & Willems, Jaap & T.Dirk Tromp, F. J. & Haaijer-Ruskamp, Flora M., 1995. "Setting the agenda: Does the medical literature set the agenda for articles about medicines in the newspapers?," Social Science & Medicine, Elsevier, vol. 41(6), pages 893-899, September.
- Sergio Sismondo, 2007. "Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?," Working Papers id:1254, eSocialSciences.
- De Vries, Raymond & Lemmens, Trudo, 2006. "The social and cultural shaping of medical evidence: Case studies from pharmaceutical research and obstetric science," Social Science & Medicine, Elsevier, vol. 62(11), pages 2694-2706, June.
- Mather, Charles, 2005. "The pipeline and the porcupine: alternate metaphors of the physician-industry relationship," Social Science & Medicine, Elsevier, vol. 60(6), pages 1323-1334, March.
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- Naci, Huseyin & Cooper, Jacob & Mossialos, Elias, 2015. "Timely publication and sharing of trial data: opportunities and challenges for comparative effectiveness research in cardiovascular disease," LSE Research Online Documents on Economics 63797, London School of Economics and Political Science, LSE Library.
- Unruh, Lynn & Rice, Thomas & Rosenau, Pauline Vaillancourt & Barnes, Andrew J., 2016. "The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?," Health Policy, Elsevier, vol. 120(7), pages 797-808.
- Ozieranski, Piotr & McKee, Martin & King, Lawrence, 2012. "The politics of health technology assessment in Poland," Health Policy, Elsevier, vol. 108(2), pages 178-193.
- Gabe, Jonathan & Chamberlain, Kerry & Norris, Pauline & Dew, Kevin & Madden, Helen & Hodgetts, Darrin, 2012. "The debate about the funding of Herceptin: A case study of ‘countervailing powers’," Social Science & Medicine, Elsevier, vol. 75(12), pages 2353-2361.
- Padamsee, Tasleem Juana, 2011. "The pharmaceutical corporation and the 'good work' of managing women's bodies," Social Science & Medicine, Elsevier, vol. 72(8), pages 1342-1350, April.
- Timmermans, Stefan & McKay, Tara, 2009. "Clinical trials as treatment option: Bioethics and health care disparities in substance dependency," Social Science & Medicine, Elsevier, vol. 69(12), pages 1784-1790, December.
- Lexchin, Joel & O'Donovan, Orla, 2010. "Prohibiting or 'managing' conflict of interest? A review of policies and procedures in three European drug regulation agencies," Social Science & Medicine, Elsevier, vol. 70(5), pages 643-647, March.
More about this item
KeywordsPharmaceuticals Sponsorship Funding Conflict of interest Clinical trials;
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:66:y:2008:i:9:p:1909-1914. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.